All treatments enhanced PD-L1 expression on TAMs (Fig. 1f), with variable induction of CD40 and HLA-DR (Supplementary Fig. 3b); PD-L1 expression on endothelial cells and tumor cells was either absent or unchanged. This evidence concerns the gene CD40 and neoplasm.